Blackstone Life Sciences and Blackstone Credit will provide PTC with $500 million in initial funding. The funding will support PTC’s goal of delivering at least one therapy every two to three years, according to an Oct. 27 Blackstone news release.
“This strategic financing will support the acceleration of PTC’s robust and diversified pipeline, business development opportunities and general corporate purposes,” PTC Therapeutics CFO Emily Hill said in the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.